Log In
Print this Print this

ProMark test

  Manage Alerts
Collapse Summary General Information
Company Metamark Genetics Inc.
DescriptionUndisclosed biopsy-based prostate cancer prognostic test
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsIdentify indolent disease in patients with prostate cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today